Analysts: Astex Pharmaceuticals Inc (ASTX.OQ)
ASTX.OQ on NASDAQ Stock Exchange Global Select Market
5.54USD
4:00pm EDT
5.54USD
4:00pm EDT
Price Change (% chg)
$0.31 (+5.93%)
$0.31 (+5.93%)
Prev Close
$5.23
$5.23
Open
$5.35
$5.35
Day's High
$5.59
$5.59
Day's Low
$5.28
$5.28
Volume
273,853
273,853
Avg. Vol
394,279
394,279
52-wk High
$6.94
$6.94
52-wk Low
$2.15
$2.15
Consensus Recommendations
| Consensus Recommendation | Next Earnings (approx.) | Company Fiscal Year End Month |
Last Updated |
|---|---|---|---|
| Outperform | -0.08 | December | 1 Aug 2013 |
Analyst Recommendations and Revisions
| 1-5 Linear Scale | Current | 1 Month Ago |
2 Month Ago |
3 Month Ago |
|---|---|---|---|---|
| (1) BUY | 1 | 0 | 0 | 0 |
| (2) OUTPERFORM | 3 | 3 | 3 | 3 |
| (3) HOLD | 0 | 0 | 0 | 0 |
| (4) UNDERPERFORM | 0 | 0 | 0 | 0 |
| (5) SELL | 0 | 0 | 0 | 0 |
| No Opinion | 0 | 0 | 0 | 0 |
| Mean Rating | 1.75 | 2.00 | 2.00 | 2.00 |
Consensus Estimates Analysis
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| # of Estimates | Mean | High | Low | 1 Year Ago |
|
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Sep-13 | 3 | 15.01 | 19.32 | 11.80 | -- |
| Quarter Ending Dec-13 | 3 | 7.32 | 9.75 | 5.20 | -- |
| Year Ending Dec-13 | 4 | 58.66 | 66.25 | 55.00 | 61.02 |
| Year Ending Dec-14 | 4 | 27.53 | 42.50 | 18.30 | 24.40 |
| Earnings (per share) | |||||
| Quarter Ending Sep-13 | 3 | -0.08 | -0.03 | -0.11 | -- |
| Quarter Ending Dec-13 | 3 | -0.15 | -0.13 | -0.18 | -- |
| Year Ending Dec-13 | 4 | -0.26 | -0.19 | -0.34 | -0.20 |
| Year Ending Dec-14 | 4 | -0.63 | -0.52 | -0.76 | -0.70 |
Historical Surprises
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| Estimates vs Actual | Estimate | Actual | Difference | Surprise % |
|---|---|---|---|---|
| SALES (in millions) | ||||
| Quarter Ending Mar-13 | 18.47 | 22.09 | 3.62 | 19.62 |
| Quarter Ending Dec-12 | 22.90 | 24.06 | 1.16 | 5.07 |
| Quarter Ending Mar-12 | 17.97 | 22.02 | 4.05 | 22.53 |
| Quarter Ending Dec-11 | 20.79 | 21.20 | 0.41 | 1.99 |
| Quarter Ending Sep-11 | 16.12 | 16.95 | 0.82 | 5.11 |
| Earnings (per share) | ||||
| Quarter Ending Mar-13 | -0.05 | 0.01 | 0.06 | -118.18 |
| Quarter Ending Dec-12 | 0.00 | 0.05 | 0.05 | 0.00 |
| Quarter Ending Jun-12 | -0.07 | 0.01 | 0.08 | -114.29 |
| Quarter Ending Mar-12 | -0.02 | 0.01 | 0.03 | -150.00 |
| Quarter Ending Dec-11 | -0.01 | 0.00 | 0.01 | -100.00 |
Consensus Estimates Trend
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| Current | 1 Week Ago |
1 Month Ago |
2 Month Ago |
1 Year Ago |
|
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Sep-13 | 15.01 | 15.01 | 12.85 | 12.85 | -- |
| Quarter Ending Dec-13 | 7.32 | 7.32 | 6.10 | 6.10 | -- |
| Year Ending Dec-13 | 58.66 | 58.66 | 56.13 | 56.13 | 61.02 |
| Year Ending Dec-14 | 27.53 | 27.53 | 27.27 | 25.85 | 24.40 |
| Earnings (per share) | |||||
| Quarter Ending Sep-13 | -0.08 | -0.08 | -0.10 | -0.10 | -- |
| Quarter Ending Dec-13 | -0.15 | -0.15 | -0.16 | -0.16 | -- |
| Quarter Ending Dec-13 | -0.26 | -0.26 | -0.28 | -0.28 | -0.20 |
| Quarter Ending Dec-14 | -0.63 | -0.63 | -0.62 | -0.64 | -0.70 |
Estimates Revisions Summary
| Last Week | Last 4 Weeks | |||
|---|---|---|---|---|
| Number Of Revisions: | Up | Down | Up | Down |
| Revenue | ||||
| Quarter Ending Sep-13 | 0 | 0 | 0 | 0 |
| Quarter Ending Dec-13 | 0 | 0 | 0 | 0 |
| Year Ending Dec-13 | 0 | 0 | 0 | 0 |
| Year Ending Dec-14 | 0 | 0 | 0 | 0 |
| Earnings | ||||
| Quarter Ending Sep-13 | 0 | 0 | 0 | 0 |
| Quarter Ending Dec-13 | 0 | 0 | 0 | 0 |
| Year Ending Dec-13 | 0 | 0 | 0 | 0 |
| Year Ending Dec-14 | 0 | 0 | 0 | 0 |
Analyst Research Reports
| Report Title | Price |
|---|---|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: S&P Capital IQ Quantitative Report
|
$69.00
|
|
Provider: Wright Reports
|
$472.00
|
|
Provider: Pechala's Reports
|
$15.00
|
|
Provider: Reuters Investment Profile
|
$20.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Earnings vs.
Estimates